As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Panelists discuss how therapy sequencing is approached for patients with chronic lymphocytic leukemia (CLL), with a focus on ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Defining remission is challenging due to imprecise CT/PET scans and genetic heterogeneity of aggressive B-cell lymphomas. Next-generation sequencing tests offer potential for more precise remission ...

The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...

UC Santa Cruz genomics experts gained new insights into the campus's endearingly eccentric mascot — and overcame the unique ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

For the first time, a new genotype of avian influenza has been identified in U.S. dairy cows, prompting biosecurity efforts.

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.